CENPH and renal cell carcinoma: In addition, CENP-H is overexpressed in cells in RCC (A704, 786-O, and ACHN), GC (AGS, MGC803, BGC823, HGC27, MKN45, MKN28, and SGC7901), nasopharyngeal carcinoma (6-10B, C666, CNE1, CNE2, SUNE-1, 5-8F, and SGC7901), LC (95D, A549, H1299, hLAMP, and PAa), ESCA (108CA and KYSE140), liver cancer (Hep3B, HepG2, HHCC, SMMC7721, and MHHC97H), BC (MCF10A, MCF7, MDA231 and MDAMB435S), and tongue cancer (TSCCa and Tca8113) (7–9, 11, 13, 16–18, 21, 22).